enow.com Web Search

  1. Ads

    related to: hemophilia treatment costs chart

Search results

  1. Results from the WOW.Com Content Network
  2. Etranacogene dezaparvovec - Wikipedia

    en.wikipedia.org/wiki/Etranacogene_dezaparvovec

    Etranacogene dezaparvovec, sold under the brand name Hemgenix is a gene therapy used for the treatment of hemophilia B. [5] [6] [7] Etranacogene dezaparvovec is an adeno-associated virus vector-based gene therapy which consists of a viral vector carrying a gene for clotting Factor IX. [7]

  3. Factor VIII (medication) - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII_(medication)

    The cost of Factor VIII and similar clotting factors has been described as "highly expensive". [21] The cost of the clotting factors is 80% of all medical costs for people with hemophilia. [ 23 ] They are so expensive that gene therapy for haemophilia might be less expensive, especially for people with severe hemophilia.

  4. Haemophilia - Wikipedia

    en.wikipedia.org/wiki/Haemophilia

    Haemophilia (British English), or hemophilia (American English) [6] (from Ancient Greek αἷμα (haîma) 'blood' and φιλία (philía) 'love of'), [7] is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.

  5. A hemophilia drug that just won FDA approval pegs a one-time ...

    www.aol.com/news/hemophilia-drug-just-won-fda...

    There’s a new one-time treatment for Hemophilia B patients in the market, but it comes with an obscene price tag. A hemophilia drug that just won FDA approval pegs a one-time $3.5 million vial ...

  6. U.S. Hemophilia Treatment Market Size to Worth US$ 6.81 ...

    lite.aol.com/tech/story/0022/20240726/9194081.htm

    Burlingame, July 26, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, U.S. Hemophilia Treatment Market was valued at US$ 4.21 Billion in the year 2023 and is anticipated to reach US$ 6.81 Billion by 2031, at a CAGR of 6.2% during forecast period 2024-2031.

  7. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    Such measures include cost-minimization, cost-benefit, cost-effectiveness, and cost-utility analysis. [119] They take into account the total costs, including hospital stays, repeated dosages, etc. and, comparing it to a similar treatment, determines whether a drug will actually minimize costs and whether it is more effective in curing the patient.

  8. FDA Approves Pfizer's Second Hemophilia Drug With Six Months

    www.aol.com/finance/fda-approves-pfizers-second...

    On Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients ...

  9. Free Genetic Testing Initiative to be Available Nationally at ...

    www.aol.com/2013/10/02/free-genetic-testing...

    Free Genetic Testing Initiative to be Available Nationally at Hemophilia Treatment Centers - My Life, Our Future pilot phase successfully completed - - Initiative aims to offer genotyping to all ...

  1. Ads

    related to: hemophilia treatment costs chart